Our patented CXU Scaffold™ Technology is a groundbreaking advancement in regenerative medicine.
Developed at the University of British Columbia, in the BC Professional Firefighters Burn and Wound Healing Lab.
Conexeu Sciences' first product is a liquid skin substitute which begins to gel in the body in about ~10 minutes.
Derived from our CXU ECM Scaffold Technology, it is an innovative skin substitute. It enhances tissue regeneration with a faster rate of wound healing and superior epithelialization.
Clinically demonstrating improved cell survival post-transplant, leading to scarless and non-fibrotic healing and effectively reduces inflammation, requiring fewer cells for better outcomes with fewer complications.
Our Liquid Skin Substitute is engineered to:
Designed to address the critical stages of wound healing.
Conexeu Sciences, Inc. is building a new class of wound care and aesthetic products from our innovative tissue research in regenerative medicine.
The company is leading the development and commercialization of cellular therapies for skin restoration. Ideal for applications in wound care such as burns, acute wounds and diabetic ulcers, with aesthetic indications for soft tissue fillers.
Revolutionizing aesthetics and wound care with our
ground-breaking patented CXU Scaffold™.
1133 Melville St, Vancouver, British Columbia V6E 0A3, Canada
info [at] conexeu.com
Conexeu Sciences Inc.
Copyright © 2024 Conexeu Sciences Inc. - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.